GlassScriptPhysician profile
Walter R Cox
NPI 1093711145
$25,353.08
in general payments reported to CMS, 2019-2025
29 companies · $2,079 in 2025
The $2,079 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,933 · 2020: $1,749 · 2021: $3,938 · 2022: $3,412 · 2023: $5,967 · 2024: $6,276 · 2025: $2,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,768 · Food and Beverage: $1,495 · Travel and Lodging: $1,059.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,768.17 |
| Food and Beverage | $1,494.76 |
| Travel and Lodging | $1,058.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10,302.54 | 2021-2025 | Nexplanon |
| Applied Medical Resources Corporation | $7,284.05 | 2022-2024 | Gelpoint V-Path |
| Merck Sharp & Dohme LLC | $4,889.90 | 2019-2025 | Gardasil 9, Gardasil |
| Coloplast Corp | $625.28 | 2023 | Altis |
| Abbvie INC. | $494.31 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $325.17 | 2021-2025 | |
| Astellas Pharma US INC | $246.78 | 2019-2025 | Veozah |
| Amgen INC. | $124.13 | 2021-2024 | Evenity, Prolia |
| Therapeuticsmd, INC. | $115.64 | 2019-2021 | |
| Exeltis, USA INC. | $113.71 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $106.85 | 2019-2025 | |
| Agile Therapeutics, INC. | $94.06 | 2021 | |
| Millicent US INC | $64.31 | 2025 | Intrarosa, Femlyv |
| Duchesnay USA Incorporated | $63.82 | 2019 | |
| Pfizer INC. | $58.26 | 2021-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $54.85 | 2020-2025 | Caldolor |
| Boston Scientific Corporation | $53.87 | 2019-2024 | |
| Integra Lifesciences Corporation | $48.15 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Exact Sciences Corporation | $38.41 | 2025 | The Cologuard Plus Collection Kit |
| Coopersurgical, INC. | $38.12 | 2019-2024 | Paragard T 380a |
| Becton, Dickinson and Company | $35.75 | 2025 | Channel Drain |
| Minerva Surgical, INC | $26.37 | 2019 | |
| Lupin INC. | $25.91 | 2019-2020 | |
| Avion Pharmaceuticals | $25.00 | 2020-2021 | |
| Ethicon US, LLC | $24.84 | 2021 | |
| Evofem Biosciences, INC. | $20.97 | 2021 | |
| Hologic Sales and Service, LLC | $19.96 | 2022 | |
| Urovant Sciences INC | $18.10 | 2022 | |
| Smith+Nephew, INC. | $13.97 | 2023 | Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.